Scientists probe whether anesthesia drug reaches unborn babies
NCT ID NCT06634355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses donated placentas from healthy pregnancies to measure how much sugammadex, a drug used to reverse anesthesia, passes from mother to baby. Researchers will test drug levels in both the maternal and fetal sides of the placenta in a lab model. The goal is to provide critical safety data for pregnant women needing this medication. Sixteen placentas will be studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a broader vitamin mix outperform standard prenatal supplements?
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Partnering up for birth: could Couples' classes boost satisfaction and memory?
- Which ripening method gets First-Time moms to vaginal delivery faster?
- Electronic monitors reveal HIV medication habits in pregnancy and beyond
- Could routine STI screening during pregnancy prevent preterm births?